Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of mogamulizumab in previously treated peripheral T-cell lymphoma
2011-004151-39Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mogamulizumab in peripheral T-cell lymphoma (PTCL), sponsored by Kyowa Kirin. Started Oct 2011; status: completed.
02
Drugs
mogamulizumab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on 2011-004151-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004151-39.